Literature DB >> 12010068

Cellular and molecular pathophysiology of cutaneous drug reactions.

Werner J Pichler1, Nikhil Yawalkar, Markus Britschgi, Jan Depta, Ingrid Strasser, Simone Schmid, Petra Kuechler, Dean Naisbitt.   

Abstract

Hypersensitivity reactions to drugs can cause a variety of skin diseases like maculopapular, bullous and pustular eruptions. In recent years increasing evidence indicates the important role of T cells in these drug-induced skin diseases. Analysis of such drug-specific T cell clones has revealed that drugs can be recognized by alpha beta-T cell receptors, not only if bound covalently to peptides, but also if the drug binds in a rather labile way to the presenting major histocompatibility complex (MHC)-peptide. This presentation is sufficient to stimulate T cells. In maculopapular exanthema (MPE), histopathological analysis typically shows a dominant T cell infiltration together with a vacuolar interface dermatitis. Immunohistochemical studies demonstrate the presence of cytotoxic CD4+ and to a lesser degree of CD8+ T cells, which contain perforin and granzyme B. They are close to keratinocytes that show signs of cell destruction. Expression of Fas ligand is barely detectable, suggesting that cytotoxic granule exocytosis may be the dominant pathway leading to keratinocyte cell damage. While in MPE, the killing of cells seems to be predominantly mediated by CD4+ T cells, patients with bullous skin disease show a strong CD8+ T cell migration to the epidermis. This is probably due to a preferential presentation of the drug by MHC class I molecules, and a more extensive killing of cells that present drugs on MHC class I molecules. This might lead to bullous skin diseases. In addition to the presence of cytotoxic T cells, drug-specific T cells also orchestrate the inflammatory skin reaction through the release and induction of various cytokines [i.e. interleukin (IL)-5, IL-6, tumor necrosis factor-alpha and interferon-gamma] and chemokines (RANTES, eotaxin or IL-8). The increased expression of these mediators seems to contribute to the generation of tissue and blood eosinophilia, a hallmark of many drug-induced allergic reactions. However, in acute generalized exanthematous pustulosis (a peculiar form of drug allergy), neutrophils represent the predominant cell type within pustules, probably due to their recruitment by IL-8 secreting drug specific T cells and keratinocytes.

Entities:  

Mesh:

Year:  2002        PMID: 12010068     DOI: 10.2165/00128071-200203040-00001

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  19 in total

1.  Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation.

Authors:  Simone Schmid; Petra C Kuechler; Markus Britschgi; Urs C Steiner; Nikhil Yawalkar; Alain Limat; Kurt Baltensperger; Lasse Braathen; Werner J Pichler
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Role of bioactivation in drug-induced hypersensitivity reactions.

Authors:  Joseph P Sanderson; Dean J Naisbitt; B Kevin Park
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

Review 3.  Hypersensitivity reactions to HIV therapy.

Authors:  Mas Chaponda; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 4.  Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.

Authors:  Sanjoy Roychowdhury; Craig K Svensson
Journal:  AAPS J       Date:  2005-12-09       Impact factor: 4.009

5.  Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.

Authors:  Payal Bhaiya; Sanjoy Roychowdhury; Piyush M Vyas; Mark A Doll; David W Hein; Craig K Svensson
Journal:  Toxicol Appl Pharmacol       Date:  2006-04-17       Impact factor: 4.219

6.  Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions.

Authors:  Said Benahmed; Marie Christine Picot; Dominique Hillaire-Buys; Jean Pierre Blayac; Pierre Dujols; Pascal Demoly
Journal:  Eur J Clin Pharmacol       Date:  2005-07-15       Impact factor: 2.953

Review 7.  [Bullous drug reactions].

Authors:  M S Hertl-Yazdi; M Hertl
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

8.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Guide for Nurses.

Authors:  Leah M Hanson; Amanda P Bettencourt
Journal:  AACN Adv Crit Care       Date:  2020-09-15

9.  Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.

Authors:  M Zöller; P Freyschmidt-Paul; M Vitacolonna; K J McElwee; S Hummel; R Hoffmann
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

10.  [Delayed-type cutaneous drug reactions. Pathogenesis, clinical features and histology].

Authors:  M Ziemer
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.